Lind Global Fund III LP

13D and 13G Filings

13D/G filings: 13G on 12 securities
Location: New York, NY
CIK: 0002071860
Form D filings: 1 filing
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Gorilla Technology Group Inc. 13G GRRR · G4000K175	GRRR	G4000K175	10.0%	3,065,081	13G	11/2/2026 Event 10/29/2026
Lind Global Fund III LP			10.0%	3,065,081
Lind Global Partners III LLC			10.0%	3,065,081
Easton Jeff			10.0%	3,065,081
Dare Bioscience, Inc. 13G DARE · 23666P200	DARE	23666P200	5.7%	1,094,890	13G	8/28/2026 Event 8/17/2026
Lind Global Fund III LP			5.7%	1,094,890
Lind Global Partners III LLC			5.7%	1,094,890
Easton Jeff			5.7%	1,094,890
DEFSEC Technologies Inc. 13G DFSC · 244778106	DFSC	244778106	10.0%	347,315	13G	8/25/2026 Event 8/18/2026
Lind Global Fund III LP			10.0%	347,315
Lind Global Partners III LLC			10.0%	347,315
Easton Jeff			10.0%	347,315
Enveric Biosciences, Inc. 13G/A Amendment 2 ENVB · 29405E505	ENVB	29405E505	1.4%	51,866	13G/A Amendment 2	8/14/2026 Event 6/30/2026
Lind Global Fund III LP			1.3%	49,366
Lind Global Partners III LLC			1.3%	49,366
Easton Jeff			1.4%	51,866
Iveda Solutions, Inc. 13G/A Amendment 1 IVDA · 46583A303	IVDA	46583A303	10.0%	1,286,794	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Lind Global Fund III LP			10.0%	1,286,794
Lind Global Partners III LLC			10.0%	1,286,794
Jeff Easton			10.0%	1,286,794
Nuwellis, Inc. 13G NUWE · 67113Y801	NUWE	67113Y801	6.2%	193,050	13G	8/5/2026 Event 8/3/2026
Lind Global Fund III LP			6.2%	193,050
Lind Global Partners III LLC			6.2%	193,050
Easton Jeff			6.2%	193,050
60 Degrees Pharmaceuticals, Inc. 13G SXTP · 83006G500	SXTP	83006G500	5.5%	191,571	13G	8/5/2026 Event 7/31/2026
Lind Global Fund III LP			5.5%	191,571
Lind Global Partners III LLC			5.5%	191,571
Easton Jeff			5.5%	191,571
C3is Inc. 13G CISS · Y18284300	CISS	Y18284300	10.0%	1,325,482	13G	7/31/2026 Event 6/28/2026
Lind Global Fund III LP			10.0%	1,325,482
Lind Global Partners III LLC			10.0%	1,325,482
Easton Jeff			10.0%	1,325,482
DEFSEC Technologies Inc. 13G/A Amendment 1 DFSC · 244778106	DFSC	244778106	4.99%	140,053	13G/A Amendment 1	7/15/2026 Event 6/30/2026
Lind Global Fund III LP			4.99%	140,053
Lind Global Partners III LLC			4.99%	140,053
Easton Jeff			4.99%	140,053
DEFSEC Technologies Inc. 13G DFSC · 244778106	DFSC	244778106	6.0%	160,077	13G	7/15/2026 Event 6/26/2026
Lind Global Fund III LP			6.0%	160,077
Lind Global Partners III LLC			6.0%	160,077
Easton Jeff			6.0%	160,077
Enveric Biosciences, Inc. 13G/A Amendment 1 ENVB · 29405E505	ENVB	29405E505	7.9%	161,232	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Lind Global Fund III LP			7.8%	158,732
Lind Global Partners III LLC			7.8%	158,732
Easton Jeff			7.9%	161,232
Innovation Beverage Group Ltd 13G/A Amendment 1 IBG · Q4933C208	IBG	Q4933C208	4.99%	56,139	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Lind Global Fund III LP			4.99%	56,139
Lind Global Partners III LLC			4.99%	56,139
Easton Jeff			4.99%	56,139
Silexion Therapeutics Corp 13G/A Amendment 2 SLXN · G1281K122	SLXN	G1281K122	4.96%	212,500	13G/A Amendment 2	5/15/2026 Event 3/31/2026
Lind Global Fund III LP			4.96%	212,500
Lind Global Partners III LLC			4.96%	212,500
Easton Jeff			4.96%	212,500
FibroBiologics, Inc. 13G FBLG · 31573L204	FBLG	31573L204	4.99%	230,234	13G	4/9/2026 Event 4/2/2026
Lind Global Fund III LP			4.99%	230,234
Lind Global Partners III LLC			4.99%	230,234
Easton Jeff			4.99%	230,234
Innovation Beverage Group Ltd 13G IBG · Q4933C208	IBG	Q4933C208	10.0%	181,562	13G	3/20/2026 Event 3/16/2026
Lind Global Fund III LP			10.0%	181,562
Lind Global Partners III LLC			10.0%	181,562
Easton Jeff			10.0%	181,562
Iveda Solutions, Inc. 13G IVDA · 46583A303	IVDA	46583A303	10.0%	1,158,920	13G	2/19/2026 Event 2/11/2026
Lind Global Fund III LP			10.0%	1,158,920
Lind Global Partners III LLC			10.0%	1,158,920
Jeff Easton			10.0%	1,158,920
Bionano Genomics, Inc. 13G/A Amendment 2 BNGO · 09075F404	BNGO	09075F404	9.4%	1,050,000	13G/A Amendment 2	2/17/2026 Event 12/31/2025
Lind Global Fund III LP			9.4%	1,050,000
Lind Global Partners III LLC			9.4%	1,050,000
Easton Jeff			9.4%	1,050,000
Enveric Biosciences, Inc. 13G ENVB · 29405E505	ENVB	29405E505	10.0%	141,265	13G	2/4/2026 Event 1/28/2026
Lind Global Fund III LP			10.0%	141,265
Lind Global Partners III LLC			10.0%	141,265
Easton Jeff			10.0%	141,265
DEFSEC Technologies Inc. 13G DFSC · 244778106	DFSC	244778106	9.9%	197,494	13G	12/23/2025 Event 12/18/2025
Lind Global Fund III LP			9.9%	197,494
Lind Global Partners III LLC			9.9%	197,494
Jeff Easton			9.9%	197,494
Silexion Therapeutics Corp 13G/A Amendment 1 SLXN · G1281K122	SLXN	G1281K122	6.4%	212,500	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Lind Global Fund III LP			6.4%	212,500
Lind Global Partners III LLC			6.4%	212,500
Easton Jeff			6.4%	212,500
Bionano Genomics, Inc. 13G/A Amendment 1 BNGO · 09075F404	BNGO	09075F404	9.9%	514,338	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Lind Global Fund III LP			9.9%	514,338
Lind Global Partners III LLC			9.9%	514,338
Easton Jeff			9.9%	514,338
Bionano Genomics, Inc. 13G BNGO · 09075F404	BNGO	09075F404	9.9%	1,005,961	13G	9/24/2025 Event 9/17/2025
Lind Global Fund III LP			9.9%	1,005,961
Lind Global Partners III LLC			9.9%	1,005,961
Jeff Easton			9.9%	1,005,961
Silexion Therapeutics Corp 13G SLXN · G1281K122	SLXN	G1281K122	9.9%	224,050	13G	9/18/2025 Event 9/12/2025
Lind Global Fund III LP			9.9%	224,050
Lind Global Partners III LLC			9.9%	224,050
Easton Jeff			9.9%	224,050

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.